Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
ACMG/AMP Variant ClassifierAmsterdam Criteria IICYP2C19 Phenotype InterpreterDLCN Score (FH)GJB2 Variant InterpreterGhent-2 Criteria (Marfan)HTT CAG Repeat (Huntington)Hereditary Thrombophilia VTE RiskRevised Bethesda GuidelinesTyrer-Cuzick Breast Risk
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.

ACMG/AMP Variant Classifier

ACMG/AMP Variant Classification (2015)

Select all applicable evidence criteria. The framework combines evidence strength to generate a 5-tier variant classification (P → LP → VUS → LB → B). This is a decision-support tool — final classification requires expert molecular pathologist review.

Pathogenic Evidence Criteria

Benign Evidence Criteria

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use

Interpreting variants identified in clinical genetic testing panels, exomes, or whole-genome sequencing.
Classifying germline variants from hereditary cancer, cardiovascular, neurological, or metabolic gene panels.
Structuring evidence for VUS (Variant of Uncertain Significance) review and reclassification decisions.
Standard framework used by all ACMG-accredited clinical laboratories and required for CAP/CLIA certification.

Last Comprehensive Review: 2026